In Parkinson’s disease experimental models, CGA pretreatment markedly diminished ROS caused by PD toxins, blocked Erk1/2 activation, prevented Akt inhibition, and averted neuronal cell death (He et al., 2024). Here, MAPK3 is linked to Parkinson disease.